Arkivum and PHARMASEAL Partner to Streamline Clinical Trial Data Archiving

Arkivum has partnered with PHARMASEAL, the provider of the Engility Trial Management Platform, which consists of a Clinical Trial Management System (CTMS) and Electronic Trial Master File (eTMF).

With the integration of Arkivum’s GxP-validated digital archiving and preservation technology, PHARMASEAL’s unified trial management platform now offers a complete, end-to-end trial technology solution.

This new streamlined process for archiving data will also encourage sponsors to consider retention requirements as a key part of their planning process at the beginning of the trial, instead of after study closeout.

PHARMASEAL customers who will leverage the Arkivum solution will benefit from a fit-for-purpose technology that guarantees the integrity and accessibility of their essential trial records and data for the long term. This includes alignment with industry good practice (set out in ICH E6 (R3)) and supports long-term inspection readiness in line with retention regulations such as EU CTR.

Arkivum CEO Chris Sigley said, “We’ve been aware of the great work that PHARMASEAL has been doing within the clinical trial space and I am now delighted to be able to officially call them a partner. This partnership will not only provide great value to PHARMASEAL’s customers, but will also increase awareness of the importance of a fit-for-purpose solution to preserve all essential clinical trial records and data.”

PHARMASEAL’s Ricky Lakhani, Chief Product Officer, added, “This partnership ensures our customers have a robust, long-term solution for data retention, guaranteeing that critical clinical trial records remain accessible, compliant, and usable for decades to come. This collaboration future-proofs data integrity, allowing our customers to meet evolving regulatory requirements and confidently leverage their valuable information long after a trial has concluded.”